AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2026)
AdaptHealth (AHCO) recorded quarterly Income from Non-Controlling Interests of $1.2 million in Q1 2026, down 5.35% quarter-over-quarter from $1.2 million in Q4 2025, and up 3.46% on a YoY basis from $1.1 million in Q1 2025.
AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
AdaptHealth's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests rose 3.46% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.8 million (up 7.49% YoY), while the FY2025 annual figure was $4.8 million, up 9.13% from the prior year.
- Income from Non-Controlling Interests was $1.2 million for Q1 2026 at AdaptHealth, down from $1.2 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $1.2 million in Q3 2025 to a low of $480000.0 in Q1 2022.
- Historically, Income from Non-Controlling Interests has averaged $1.1 million across 5 years, with a median of $1.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests soared 535.06% in 2022, then declined 12.43% in 2023.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $1.0 million in 2022, then dropped by 8.75% to $928000.0 in 2023, then gained by 22.95% to $1.1 million in 2024, then gained by 8.06% to $1.2 million in 2025, then fell by 5.35% to $1.2 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | AdaptHealth | 1.30 Bn | 1.26 Bn | 111.50 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 968,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 480,000.00 |
| Dec 31, 2021 | 529,000.00 |
| Sep 30, 2021 | 174,000.00 |
| Jun 30, 2021 | 951,000.00 |